C21

Drug identity checked against registry records

Also recorded as Buloxibutid, Compound 21

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Trial to Investigate Recovery From COVID-19 With C21 in Adult SubjectsNCT04880642Vicore Pharma ABPhase 3Completed2022-04-25Actual
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPFNCT04533022Vicore Pharma ABPhase 2Completed2024-03-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.